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Human cognitive ability shows consistent, positive associations with fitness
components across the life-course. Underlying genetic variation should there-
fore be depleted by selection, which is not observed. Genetic variation in
general cognitive ability (intelligence) could be maintained by a mutation–
selection balance, with rare variants contributing to its genetic architecture.
This study examines the association between the total number of rare stop-
gain/loss, splice andmissense exonicvariants andcognitive ability in childhood
and old age in the same individuals. Exome array data were obtained in the
Lothian Birth Cohorts of 1921 and1936 (combinedN ¼ 1596). General cognitive
abilitywas assessed at age 11 years and in late life (79 and 70 years, respectively)
and was modelled against the total number of stop-gain/loss, splice, and mis-
sense exonic variants, with minor allele frequency less than or equal to 0.01,
using linear regression adjusted for age and sex. In both cohorts and in both
the childhood and late-life models, there were no significant associations
between rare variant burden in the exome and cognitive ability that survived
correction for multiple testing. Contrary to our a priori hypothesis, we observed
no evidence for an association between the total number of rare exonic variants
and either childhood cognitive ability or late-life cognitive ability.1. Introduction
Selection is expected to deplete genetic variation in traits over time [1]. This
makes the existence of standing genetic variation puzzling in heritable traits
that are consistently associated with fitness components [2]. Individual differ-
ences in various human cognitive abilities tend to be strongly correlated with
each other, allowing the extraction of a single latent dimension that usually
explains about 50% of the variation in broad batteries of cognitive tasks. This
dimension is known as human general cognitive ability or general intelligence,
conventionally abbreviated as g [3–5]. Twin, family and adoption studies con-
sistently show that g is highly heritable in adulthood (50–80%) [6]. At the same
time, g shows consistent, positive associations with fitness components such as
lower mortality rate [7], better physical and mental health throughout the life-
span [8,9], height [10], developmental stability [11,12], sperm quality [13] and
higher social status and resource acquisition potential, including better edu-
cational [14] and occupational success [15]. Furthermore, higher g is preferred
in human mate choice [16–18]. This makes it unlikely that g adheres to the
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current genetic variation has been affected by directional
selection, probably even more so historically, before the
demographic transition [2,19,20]. Genetic variation can be
maintained under directional selection in complex, dimen-
sional traits such as cognitive ability when new, mostly
deleterious mutations affecting the trait occur at a rate equal
to how quickly they can be removed by selection, a state
called mutation–selection balance [2]. Various estimation
methods, including those based on genome-wide sequencing
of parent–offspring trios, concur with high human genome-
wide mutation rates [21]. Cognitive ability is not localized to
a specific region of the brain, but instead is affected by exten-
sive neural networks and brain-wide neuronal integrity
[4,22,23]. Furthermore, associations with distal phenotypic
measures such as fluctuating asymmetry of the body and
face [11,12,24], as well as sperm quality [13], suggest that it is
an indicator of overall system integrity or phenotypic condition
[25]. These lines of evidence imply that harmful mutations
in many parts of the genome might be able to affect cognitive
ability [26], i.e. via a large mutational target size [27].
Since selection will quickly purge genetic variants with
strong effects on fitness-related traits, genetic variation
maintained by mutation–selection balance suggests a genetic
architecture that lacks common genetic variants of notable
effect sizes [2,28]. This is in line with the lack of replicable
findings from candidate gene studies of cognitive ability [29]
and the results from recent genome-wide association studies
(GWAS) that suggest no individual common single nucleotide
polymorphism (SNP) in the human genome explains more
than 0.24% of the genetic variation [30]. However, genome-
wide complex trait analyses (GCTA), which estimate cryptic
distant genetic relationships in population samples from
genome-wide SNP data, suggest heritabilities for g in the
range of 30–50% [31]. Since these estimates are purely based
on genome-wide common SNPs, they imply that a large part
of the genetic architecture of g consists either of common gen-
etic variants with individually miniscule phenotypic effects,
or of rare genetic variants that have been in the population
for long enough that they are in sufficient linkage dis-
equilibrium with the common SNP markers present on
commercial genotyping arrays. More recent mutations, includ-
ing family-specific and private de novo genetic variants, could
explain the discrepancy in heritability estimates from GCTA
compared to those from twin, family and adoption studies [32].
A genetic architecture based on rare genetic variants
implies high genetic heterogeneity [26,28] and makes extre-
mely large samples necessary for genome-wide scans in
order to detect individual causal variants, even if they have
moderate-to-large effect sizes [32]. A different approach
which is less affected by statistical power issues is to consider
the total number of rare variants that an individual carries
and then relate this to phenotypic traits. This approach
relies on the assumption that it is the overall burden of dele-
terious mutations that should explain genetic variation in
traits such as g, while the individual causal variants might
be heterogeneous and interchangeable [26]. Using an estimate
of genomic burden of rare copy number variants (CNVs), Yeo
et al. [33] found a negative association between mutation
burden and cognitive ability in a small sample of 74 individ-
uals with alcohol dependence. However, three replication
studies in much larger samples, using various estimates of
genome-wide CNV burden, were unable to replicate thisfinding [34–36]. A different approach to mutation load is to
look at the overall burden of rare (minor allele frequency,
MAF  0.01) SNPs in the exome. To our knowledge, no study
has yet looked at rare exomic SNP burden in relation to g. The
recently developed exome array (http://genome.sph.umich.
edu/wiki/Exome_ Chip_Design), which genotypes rare var-
iants identified from the exome sequencing of around 12 000
persons, provides an ideal resource to test this hypothesis.
While the rank-order stability of cognitive ability is high
even from childhood to old age [37,38], cognitive ability
does undergo differential age-related changes [39,40]. It is
unclear whether the detrimental effects of exonic mutations
affect cognitive ability equally across the lifespan, or alterna-
tively more in the pre-reproductive life stage (childhood),
when selection pressures against them should be stronger
but higher developmental plasticity should provide a better
buffer, or in the post-reproductive life stage (old age), when
plasticity is low but selection pressures are assumed to be
less effective against detrimental genetic effects [41].
The aim of this study was to examine the relationship
between an individual’s total number of rare exonic variants
(SNPs with MAF  0.01) with cognitive ability measured in
the same individuals at two points in life, during childhood
and old age.2. Methods
(a) Population
Data stem from two Scottish birth cohorts: the Lothian Birth
Cohorts (LBC) of 1921 (LBC1921) and 1936 (LBC1936), which
are longitudinal studies of ageing [42–44].
LBC1921 participants were born in 1921 and most comple-
ted the Scottish Mental Survey 1932 (SMS1932) at mean age 11
years [45]. The SMS1932 assessment was administered nationwide
to all 1921-born childrenwho attended school in Scotland on 1 June
1932 and included the Moray House Test no. 12, which provides a
measure of general cognitive ability. They were therefore tested at
a mean age of 11 years. The LBC1921 attempted to follow up rela-
tively healthy individuals who completed the SMS1932 in
the Lothian region of Scotland (the area around Edinburgh city);
550 people were successfully traced and participated in the
study from mean age 79 years. At present, there have been four
waves of follow-up at mean ages 79, 83, 87 and 90 years where
extensive cognitive, lifestyle, biomarker, neuroimaging, genetic
and epigenetic data have been collected [42].
The design of LBC1936 is similar to LBC1921. Participants
were born in 1936 and completed the SMS1947, which was admi-
nistered nationwide to all children born in that year who attended
school in Scotland on 4 June 1947 [46]. The Moray House Test
no. 12 was used to assess cognitive ability. The LBC1936 follows
up 1091 relatively healthy survivors from the SMS1947 who
were living in the Lothian area at age about 70 years. Additional
waves of data collection have been carried out at mean ages 73
and 76 years. As with LBC1921, extensive cognitive, lifestyle,
biomarker, neuroimaging, genetic and epigenetic data have been
collected across waves [42].
(b) Ethics
Following informed consent, venesected whole blood was
collected for DNA extraction in both LBC1921 and LBC1936.
Ethics permission for the LBC1921 was obtained from the Lothian
Research Ethics Committee (wave 1: LREC/1998/4/183; wave 2:
LREC/2003/7/23; wave 3: 1702/98/4/183) and the Scotland
A Research Ethics Committee (wave 4: 10/S1103/6). Ethics
Table 1. Descriptive summary of LBC1921 and LBC1936 data in both
childhood and late life. MAF, minor allele frequency.
mean s.d.
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Research Ethics Committee for Scotland (wave 1: MREC/01/0/
56), the Lothian Research Ethics Committee (wave 1: LREC/
2003/2/29) and the Scotland A Research Ethics Committee
(waves 2 and 3: 07/MRE00/58). Written informed consent was
obtained from all subjects.LBC1921 (n ¼ 497, 59% female)
childhood age (years) 10.9 0.29
late-life age (years) 79.0 0.58
Moray House Test no. 12 (age 11)
(n ¼ 446)
46.8 12.0
Moray House Test no. 12 (age 79)
(n ¼ 492)
59.4 11.0
ﬂuid general cognitive ability, ga
(n ¼ 486)
0.0 1.0
total number of rare alleles
(MAF  0.01)
185.9 16.7
total number of rare alleles
(MAF  0.05)
562.4 28.1
LBC1936 (n ¼ 988, 50% female)
etypublishing.org
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For the current analysis, we consider two measures of cognitive
ability. The same measure of general cognitive ability, the Moray
House Test [45,46], was administered in childhood (age 11) and
later life (age 79 in LBC1921, age 70 in LBC1936). It has a scoring
range between 0 and 76. In addition, in late life, a principal com-
ponents analysis was used to derive a fluid general cognitive
ability factor for each cohort from the following cognitive test bat-
teries: in LBC1921, the fluid cognitive tests included Raven’s
standard progressive matrices [47], verbal fluency [48] andWechs-
ler logical memory [49]; in LBC1936, the test battery included six
tests from the Wechsler Adult Intelligence Scale-III UK (WAIS-III
UK) [50]: digit symbol coding, block design, matrix reasoning,
digit span backwards, symbol search and letter–number sequen-
cing. z-standardized scores from the first principal component,
which follow a Gaussian distribution with mean 0, variance 1,
were saved and used as the measure of late-life cognitive ability.childhood age (years) 10.9 0.28
late-life age (years) 69.6 0.84
Moray House Test no. 12 (age 11)
(n ¼ 940)
49.0 11.8
Moray House Test no. 12 (age 79)
(n ¼ 987)
64.3 8.8
ﬂuid general cognitive ability, ga
(n ¼ 983)
0.0 1.0
total number of rare alleles
(MAF  0.01)
184.7 16.7
total number of rare alleles
(MAF  0.05)
560.9 28.3(d) Exome chip data
Genotype data were collected on the Illumina HumanExome gen-
otyping array. Initial quality control was performed according to
the CHARGE consortium criteria [51], leaving a total of 237 603
SNPs for analysis in 508 LBC1921 participants and 988 LBC1936
participants. A second stage of quality control was then conducted
in Plink [52,53]. Firstly, haploid heterozygous calls were set to
missing (n ¼ 3590 in LBC1921, n ¼ 8248 in LBC1936). Monomor-
phic SNPs (n ¼ 164 711 in LBC1921, n ¼ 154 692 in LBC1936),
SNPs with a call rate less than 97% (n ¼ 76 in LBC1921, 66 in
LBC1936), and individuals with a call rate less than 97% (n ¼ 8
in LBC1921, 1 in LBC1936) were removed. This left a total of 72
016 SNPs for downstream analysis in LBC1921 and 82 845 SNPs
in LBC1936.aStandardized variables, derived from principal components analysis.(e) Measure of global burden
From the cleaned exome array data, stop-gain/loss, splice and
missense SNPs with a MAF of less than or equal to 0.01 were
extracted (n ¼ 36 200 in LBC1921, n ¼ 46 384 in LBC1936). The
global burden of rare variants for each individual was defined
as the total number of rare variant alleles (an additive model).( f ) Statistical analysis
Linear regression models were built to assess the relationship
between rare variant burden and childhood and late-life cognition
in LBC1921 and LBC1936. Mean-centred age at cognitive assess-
ment and sex were included as covariates in each model. The
global burden of rare variants followed a Gaussian distribution;
however, a few extreme outliers were removed prior to analysis
(n ¼ 2 in LBC1921, n ¼ 3 in LBC1936). All models were re-run as
part of a sensitivity analysis that used a less stringent cut-off for
rare variants (MAF  0.05, nSNPs ¼ 44 045 in LBC1921 and
nSNPs¼ 54 439 in LBC1936). Models were also run at both the 1%
and 5% MAF threshold to analyse individually the effects of rare
variant burden on cognition for (i) stop-gain/loss, (ii) splice, (iii)
missense and (iv) all variants, including synonymous SNPs. Diag-
nostic plots were examined to check model fit. All analyses were
conducted in R [54]. Analysis code and a data file containing anon-
ymized age, sex, cognitive test scores, and global burden data butnot raw genetic data are available from the corresponding author
on request.3. Results
Descriptive data are presented in table 1. Owing to missing
cognitive data there were slight differences in sample sizes
in childhood and late life. At age 11, cognitive data were
available on 446 LBC1921 and 940 LBC1936 participants. In
late life these increased to 492 and 987, respectively. The
mean ages of the samples in childhood were 10.9 years
(s.d., 0.29) in LBC1921 and 10.9 years (s.d., 0.28) in
LBC1936; in late life the mean ages of the samples were
79.0 (s.d., 0.58) and 69.6 (s.d., 0.84), respectively. The
gender distribution was 59% female in LBC1921 and 50%
female in LBC1936.
The mean Moray House Test scores in childhood were
46.8 (s.d., 12.0) and 49.0 (s.d., 11.8) in LBC1921 and
LBC1936, respectively. The corresponding values in late life
were 59.4 (s.d., 11.0) and 64.3 (s.d., 8.8). The mean numbers
of rare variants per individual were 185.9 (s.d., 16.7) in
LBC1921 and 184.7 (s.d., 16.7) in LBC1936.
Table 2. Age and sex adjusted linear regressions of burden (sum of variants with minor allele frequency less than or equal to 0.01) against childhood and late-
life general cognitive ability (Moray House Test). LBC, Lothian Birth Cohort; MHT, Moray House Test scores; b, unstandardized beta; s.e., standard error; p,
p-value.
b s.e. p b s.e. p
LBC1921 childhood MHT LBC1921 late-life MHT
intercept 55.42 6.38 ,0.001 62.63 5.54 ,0.001
age (years) 7.97 1.95 ,0.001 21.19 0.86 0.16
sex (female) 0.23 1.13 0.84 22.84 1.00 0.005
burden 20.047 0.034 0.17 28.4  1023 0.030 0.78
LBC1936 childhood MHT LBC1936 late-life MHT
intercept 48.38 4.22 ,0.001 67.38 3.11 ,0.001
age (years) 7.48 1.36 ,0.001 21.47 0.33 ,0.001
sex (female) 1.75 0.76 0.021 20.41 0.56 0.46
burden 21.2  1023 0.023 0.96 20.016 0.017 0.35
Table 3. Age and sex adjusted linear regressions of burden (sum of variants with minor allele frequency  0.01) against late-life ﬂuid cognitive ability factors.
LBC, Lothian Birth Cohort; g, ﬂuid general cognitive ability; b, unstandardized beta; s.e., standard error; p, p-value.
LBC1921 late-life g LBC1936 late-life g
b s.e. p b s.e. p
intercept 0.43 0.51 0.40 20.36 0.34 0.30
age (years) 20.14 0.079 0.075 20.32 0.037 ,0.001
sex (female) 20.27 0.093 0.004 20.057 0.061 0.35
burden 21.4  1023 2.7  1023 0.62 2.1  1023 1.8  1023 0.26
rspb.royalsocietypublishing.org
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general cognitive ability with adjustment for age and sex.
There were no significant associations between burden of
rare alleles and age-11 Moray House Test scores (LBC1921:
b ¼ 20.047 (s.e., 0.034), p ¼ 0.17; LBC1936: b ¼ 1.2  1023
(s.e., 0.023), p ¼ 0.96). Similar null findings were observed
between burden and late-life Moray House Test scores
(LBC1921: b ¼ 28.4  1023 (s.e., 0.030), p ¼ 0.78; LBC1936:
b ¼ 20.016 (s.e., 0.017), p ¼ 0.35). There were also null find-
ings for the late-life models of burden against fluid general
cognitive ability (LBC1921: b ¼ 21.4 1023 (s.e., 2.7 1023),
p ¼ 0.62; LBC1936: b ¼ 2.1 1023 (s.e., 1.8  1023), p ¼ 0.26),
which are presented in table 3.
Some age and sex effects were observed in both early
and late life and for both general and fluid cognitive ability
(tables 2 and 3). Females were more likely to have slightly
higher Moray House Test scores at age 11 (b ¼ 0.23, p ¼ 0.84
in LBC1921, b ¼ 1.75, p ¼ 0.021 in LBC1936) and slightly
lower scores in later life (b ¼ 22.84, p ¼ 0.005 in LBC1921,
b ¼ 20.41, p ¼ 0.46 in LBC1936). A similar pattern was seen
for the late-life fluid abilities (b ¼ 20.27, p ¼ 0.004 in
LBC1921, b ¼ 20.057, p ¼ 0.35 in LBC1936). Older children
performed better on the Moray House Test at age 11 by
around eight points per year (p, 0.001) but older adults had
lower Moray House Test (b ¼ 21.20, p ¼ 0.16 in LBC1921,
b ¼ 21.47, p, 0.001 in LBC1936) and g scores (b ¼ 20.14,
p ¼ 0.075 in LBC1921, b ¼ 20.32, p, 0.001 in LBC1936) in
late life.Sensitivity analyses that included SNPs with a MAF less
than 0.05 yielded near identical null associations to the
models with a MAF cut-off of 0.01 (electronic supplementary
material, tables S1 and S2). There were no associations
between burden and cognitive ability for the models that con-
sidered (i) stop-gain/loss, (ii) splice, (iii) missense and (iv) all
variants, including synonymous SNPs (electronic supplemen-
tary material, tables S3–S6). The only exception was for the
splice variants in LBC1936, where a unit increase in rare var-
iant burden decreased the childhood and late-life MHT scores
by 0.3 points ( p ¼ 0.039 and 0.011, respectively). However,
these associations were not significant after a Bonferroni
correction to account for multiple testing.4. Discussion
In this study, we found no evidence of a significant association
for an individual’s total number of rare exonic single nucleotide
variantswith childhood or late-life cognitive ability. Null associ-
ations were observed in all analyses after correction for multiple
testing, suggesting that there is no link of total number of rare
exonic stop-gain/loss, splice and missense SNPs with cognitive
ability across the life-course in these two samples.
To our knowledge, this is the first time that a global sum
score of rare exonic variants, representing mutation load,
has been modelled with cognitive ability, a trait that correla-
tes highly with several fitness components from across the
rspb.royalsocietypublishing.org
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ible to investigate rare variant burden with cognitive measures
from both childhood and late life. Unlike genome-wide studies
of individual rare variants, or gene-based burden tests, this
study is not hampered by statistical power issues and multiple
testing of large numbers of genetic variants. However, our
analysis is not designed to, nor is it able to, identify pathways
that may link rare variants to cognitive ability.
One limitation of our analysis may be the lack of coverage
on the exome array. Although over 36 000 rare SNPs were
examined in each cohort, this does not include all rare variants
that would be typed via whole-genome or whole-exome
sequencing. Furthermore, the minor allele cut-off point for
rare variants of 0.01 may have been too low (conservative)
for the present analysis although re-adjusting this to 0.05 in
a secondary analysis made no difference in the findings.
A possible explanation for our null finding might be that
rare non-synonymous exonic SNPs, which make up the bulk
(approx. 96%) of our variants, are not the right place to look
for genetic variants explaining normal variation in cognitive
ability. Non-synonymous exonic variants alter protein struc-
tures, which might result in too radical phenotypic effects
to be observed in the normal, healthy population range.
A sensitivity analysis that considered the burden of both
synonymous and stop-gain/loss, splice and missense var-
iants made very little difference to the association between
total burden score cognitive ability. Exonic point mutations
have been found to be mostly recent [55], which would be
expected if they are strongly selected against for their large
negative effects on fitness. Interestingly, Rauch et al. [56]
found de novo point mutations were overrepresented in
patients with severe non-syndromic intellectual disability
(the low end of the cognitive ability continuum) compared
with controls in an exome sequencing study and identified
several loss-of-function exonic variants associated with intel-
lectual disability. This contrasts with our study, which was
not able to find similar effects in the normal, healthy range
of cognitive ability differences. Indeed, the limited available
evidence on the influence of de novo mutations on normal-
range cognitive ability, stemming from genome-sequencing
studies of parent–offspring trios [57] and associations of cog-
nitive ability with paternal age [58–60], an indirect marker
for de novo mutation load [61,62], suggests no such effects.
This might be because de novo mutations, which have
not experienced counteracting evolutionary selection yet,
have mostly strong negative effects on cognitive ability
and thus do not contribute to normal-range variation, and
penetrant non-synonymous rare exonic variants might be
overrepresented among them. Rare variants withmore moder-
ate effects that contribute to variation in normal cognitive
ability might thus be more probably located in the intronic
parts of the genome, and burden scores from whole-genome
sequencing studies will thus be necessary to establish their
effect. This would also imply that, in the normal range, non-
synonymous mutational burden in intronic and exonic regions
should be not or only weakly correlated, as it can be expected
that the latter has much more severely negative phenotypic
effects than the former. Against this background, it can be
predicted that the overall burden of non-synonymous rare
variants in intronic regions of the genome should negatively
predict general cognitive ability in the normal range. Testing
the mutation–selection balance model of intelligence thisway will be possible in the near future based on whole-
genome sequencing data. Finally, we did not examine potential
genegene or geneenvironment interactions.
Analyses such as the one conducted in this paper may
also be better applied to complex traits with dichotomous
end-points [26] e.g. Alzheimer’s disease (AD) versus no-
AD. Although general cognition in childhood and late life
is an excellent marker of future disease risk and other comor-
bidities, there is no set threshold beyond which impaired
functioning can be classified. Moreover, the LBCs are based
on relatively healthy, successfully ageing subjects with exclu-
sions made for dementia or severe cognitive impairment at
(late life) baseline. The relatively old age at study entry,
especially in LBC1921, may also have a bearing on the find-
ings, with low-IQ individuals and those with poorer quality
genes, health and fitness having died prior to this point. Fur-
thermore, the average childhood cognitive scores for the LBC
samples are higher, and with lower standard deviations than
those of the general population of 11 year olds that completed
the Scottish Mental Surveys of 1932 and 1947 [63]. The mean
childhood Moray House Test score for LBC1921 was 46.8
(s.d., 12.0) compared with a national average of 34.5 (s.d.,
15.5) [63]. The corresponding mean score for LBC1936 was
49.0 (s.d., 11.8), compared with the national and an Edin-
burgh, Fife and Lothians averages of 36.7 (s.d., 16.1) and
40.3 (s.d., 15.5), respectively [63]. Such range restriction on
both mutation load and intelligence might have reduced
our power to find a significant result. To this point, the stan-
dard deviation we found for exomic mutation load in both of
our samples (16.7) was somewhat less than the lower bound
of the standard deviation of Keller & Miller [64] estimated for
disruptive exomic mutation load in humans.
In conclusion, contrary to our a priori hypothesis, we
observed no evidence for an association between the total
number of rare exonic variants and cognitive ability in child-
hood and old age. Future studies await the availability of
whole-genome sequencing data in order to test associations
of rare variant burden in the whole genome. These studies
should also consider additional measures of fitness to see
whether our findings are more widely applicable to other
traits that can be considered being under mutation–selection
balance. Ideally, these analyses should be conducted on popu-
lations where a full spectrum of the fitness measure is
represented or where there is a well-defined dichotomous
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